Fast Facts: CAR T-Cell Therapy (Original Publisher)

Fast Facts: CAR T-Cell Therapy offers a clear, evidence-based overview of one of the most promising and rapidly evolving areas in cancer immunotherapy. This guide provides healthcare providers, hematologists, oncologists, and medical researchers with the critical knowledge needed to integrate CAR T-cell therapy into patient care—from patient selection to adverse event management and long-term monitoring.

CAR T-cell therapy is revolutionizing treatment approaches in hematologic malignancies and expanding into solid tumors. As its application widens, clinicians must stay informed on complex procedures, safety protocols, and patient education strategies. This book delivers those insights in a fast-access format, making it the ideal tool for busy practitioners and students in the field.

Key Features and Highlights:

• Clear Overview of CAR T Technology: Understand the science behind T-cell engineering and its role in immune-mediated cancer therapy.
• Practical Clinical Application: Learn the steps from leukapheresis and cell processing to infusion and patient follow-up.
• Side Effect Management: Gain expert guidance on recognizing and managing cytokine release syndrome (CRS), neurotoxicity, and other therapy-related toxicities.
• Real-World Integration: Designed for implementation in both academic and clinical settings with regulatory considerations and logistical workflows.
• Up-to-Date and Evidence-Based: Reflects the state of CAR T therapy as of 2021, including FDA-approved indications and pivotal trial data.

Chapters and Topics Covered:
Includes core chapters on:

• CAR T-cell mechanism of action
• Indications and eligibility for treatment
• Manufacturing process and infusion protocol
• Managing treatment-related toxicities (e.g., CRS, ICANS)
• Post-treatment monitoring and outcomes
• Challenges and future directions in CAR T-cell therapy

About the Authors:
Authored by leading clinicians and researchers in cellular immunotherapy, this title features contributions from experts involved in pioneering CAR T-cell clinical trials and patient care innovations.

Technical Details:

• Format: PDF
• File Size: Approx. 4–6 MB
• Language: English
• Compatibility: Works on all major devices including tablets, smartphones, eReaders (Kindle, iBooks), and desktop platforms

Frequently Asked Questions (FAQs)

Q1: Is this book appropriate for non-specialist healthcare providers, such as general oncologists or oncology nurses?
A1: Absolutely. While it provides in-depth clinical information, the book is written in a clear, accessible style that benefits a wide range of healthcare professionals, including general oncologists, oncology nurses, pharmacists, and advanced practice providers.

Q2: Does the book include real-world clinical considerations for CAR T-cell therapy administration?
A2: Yes, it includes practical insights into patient selection, workflow logistics, and safety monitoring, making it highly relevant for both academic and community practice settings.